POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.
Did Not Advance

Kansas Bill Permits Pharmacists to Initiate Therapy and Dispense 90-Day Emergency Refills

Original title: AN ACT concerning pharmacists and pharmacy; relating to a pharmacist's scope of practice; permitting a pharmacist to initiate therapy for certain conditions consistent with the pharmacist's education, training and experience; adding pharmacists who initiate such therapy to the healthcare stabilization fund; allowing for a 90-day emergency supply of a noncontrolled prescription drug to be filled when no refills remain; amending K.S.A. 40-3402 and K.S.A. 2025 Supp. 65-1626a and 65-16,131 and repealing the existing sections.

Last action · April 10, 2026: Died in Senate Committee

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Proposed

Kansas HB 2676 expands pharmacists' scope of practice to independently initiate therapy for certain minor, s, patient emergencies, or specific statewide protocols like influenza and urinary tract infections, and allows dispensing up to a 90-day emergency supply of noncontrolled drugs when no refills remain.

Why it matters

Expands patient access to routine medications and minor illness treatments directly through local pharmacies while establishing mandatory liability insurance requirements for independent-initiating pharmacists by January 1, 2028.

Who It Would Have Affected

Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.

Directly affected

Pharmacists

Gains authority to independently initiate therapy for minor conditions and emergency refills while facing new professional liability insurance mandates starting in 2028.

Directly affected

Patients

Obtains expanded access to immediate treatment for minor illnesses and up to 90-day emergency supplies of noncontrolled prescription drugs.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Can a pharmacist prescribe any medication under this bill?
No. Pharmacists may initiate therapy for specific minor or emergency conditions and protocol-governed illnesses like influenza, strep throat, and urinary tract infections, but they remain barred from prescribing controlled substances except for opioid use disorder treatments.
How long of an emergency supply can a pharmacist dispense if a prescription runs out?
A pharmacist may dispense a one-time emergency refill of a noncontrolled prescription drug for up to a 90-day supply when no refills remain, provided professional judgment dictates it is necessary to prevent an interruption of care.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

This bill did not become law - Died in committee.

Procedural history

12 actions
  1. Apr 10, 2026Senate
    Died in Senate Committee
  2. Feb 26, 2026SenateCommittee
    Referred to Senate Committee on Public Health and Welfare
  3. Feb 25, 2026House
    Engrossed on Monday, February 23, 2026
  4. Feb 25, 2026SenateIntroduced
    Received and Introduced
  5. Feb 19, 2026HouseFloor
    Final Action - Passed as amended
  6. Feb 18, 2026House
    Committee of the Whole - Now working on
Show 6 earlier actions
  1. Feb 18, 2026HouseFloor
    Committee of the Whole - Committee Report be adopted
  2. Feb 18, 2026HouseFloor
    Committee of the Whole - Be passed as amended
  3. Feb 17, 2026HouseFloor
    Committee Report recommending bill be passed as amended by
  4. Feb 10, 2026House
    Hearing: Tuesday, February 10, 2026, 1:30 PM — Room 112-N
  5. Feb 3, 2026HouseIntroduced
    Introduced
  6. Feb 3, 2026HouseCommittee
    Referred to House Committee on Health and Human Services

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Connected Entities

House Committee on Health and Human Services, Collaborative Drug Therapy Management Advisory Committee, University of Kansas Medical Center
OrganizationHouse Committee on Health and Human Services“Bill sponsor in the Kansas House of Representatives”Map →
OrganizationCollaborative Drug Therapy Management Advisory Committee“Advisory committee authorized to adopt statewide protocols”Map →
OrganizationUniversity of Kansas Medical Center“Referenced regarding residency training and self-insurance provisions”Map →

Sources

Open source document

www.kslegislature.gov

Analysis Score

0–100
  • Significance20
    Lowered because this bill did not pass (its text scored 75)
  • Controversy45
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record